HR 3223
116th Congress
House
Health
Competition and antitrust
Congressional oversight
Consumer affairs
Drug therapy
Government studies and investigations
Health care costs and insurance
Health care coverage and access
Inflation and prices
Prescription drugs
User charges and fees
Pharmacy Benefit Manager Accountability Study Act of 2019
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 13, 2019
Referred to the Subcommittee on Health.
Jun 12, 2019
Referred to the House Committee on Energy and Commerce.
Jun 12, 2019
Introduced in House
Plain-English summary
Pharmacy Benefit Manager Accountability Study Act of 2019
This bill requires the Government Accountability Office to study the role of pharmacy benefit managers (PBMs) with respect to federally facilitated exchanges, including the role of PBMs in pharmaceutical supply chains, the competition among PBMs, and the use of rebates and fees by PBMs in such exchanges.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2